JP Morgan increased its stake in Innovent Bio (01801) by approximately 2.55 million shares at a price of approximately HK$80.68 per share.

20:25 05/11/2025

On October 30, Morgan Stanley increased its holdings in Sinopharm Group (01801) by 2,550,546 shares, with an average price of HK$80.6819 per share, for a total amount of approximately HK$206 million.

The latest data from the Hong Kong Stock Exchange shows that on October 30th, JP Morgan increased its holdings of INNOVENT BIO (01801) by 2,550,546 shares, with a price of 80.6819 Hong Kong dollars per share, for a total amount of approximately 206 million Hong Kong dollars. After the increase, JP Morgan now holds approximately 87.0232 million shares, accounting for 5.07% of the total shares.

US Stock Market Move | Tianrui Company (TDC.US) Soars Over 26% with Q3 Performance Exceeding Expectations

US Stock Market Move | Eli Lilly (LLY.US) rises nearly 3% and reaches a AI large molecule research and development cooperation with Crystal Tai Technology in the field of dual antibodies.

US Stock Market Move | So-Young International, Inc. Sponsored ADR Class A (SY.US) surged by more than 14% and will announce its Q3 financial report before the market opens on November 17th.

US Stock Market Move | Tianrui Company (TDC.US) Soars Over 26% with Q3 Performance Exceeding Expectations

US Stock Market Move | Eli Lilly (LLY.US) rises nearly 3% and reaches a AI large molecule research and development cooperation with Crystal Tai Technology in the field of dual antibodies.

US Stock Market Move | So-Young International, Inc. Sponsored ADR Class A (SY.US) surged by more than 14% and will announce its Q3 financial report before the market opens on November 17th.